AstraZeneca revises vaccine efficacy rate to 76%

Download

00:56

AstraZeneca said its COVID-19 vaccine is 76 percent effective for preventing symptomatic illness after a new analysis of updated U.S. trial results. It's down from the 79-percent efficacy rate previously announced.

Open in CGTN APP for better experience

Search Trends